Amesite Inc. (NASDAQ:AMST), a leading artificial intelligence software company offering a cloud-based learning platform for business and education markets, announces today the demonstration of AI generated content with AI narration capabilities on its recently launched Version 6.0 platform, complementing its recent GPT-4 integration. The capabilities, demonstrated in Amesite’s free-to-the-public course on ChatGPT, demonstrate how content can be created with high efficiency and scalability, along with purpose-built, AI-driven features to support user learning.
Why Evofem Biosciences Shares Are Plunging Today?
Evofem Biosciences Inc's (OTC: EVFM) recently completed the Phase 3 EVOGUARD trial evaluating Phexxi vaginal gel (EVO100) to prevent chlamydia and gonorrhea infection in women but did not achieve its endpoints.
